|

Costotransverse Foramen Block Versus Thoracic Paravertebral Block in Thoracotomy for Lung Cancer

RECRUITINGN/ASponsored by National Cancer Institute, Egypt
Actively Recruiting
PhaseN/A
SponsorNational Cancer Institute, Egypt
Started2026-01-24
Est. completion2026-06-01
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07367581

Summary

This study aims to compare the costotransverse foramen block (CTFB) with thoracic paravertebral block (TPVB) in patients undergoing thoracotomy for lung cancer.

Eligibility

Age: 18 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age \> 18 years and ≤ 65 years old.
* American Society of Anesthesiologists (ASA) physical status II-III.
* Body mass index 18-35 kg/m2.
* Patients scheduled for thoracotomies for lung cancer.

Exclusion Criteria:

* Patient refusal.
* History of sensitivity to local anesthetics.
* History of psychological disorders.
* Contraindication to regional anesthesia, e.g., local sepsis, pre-existing peripheral neuropathies, and coagulopathy.
* Severe respiratory, cardiac, hepatic, or renal disease.
* Morbid obesity.
* Uncooperative patients.
* Patients on chronic pain therapy.

Conditions5

CancerCostotransverse Foramen BlockLung CancerThoracic Paravertebral BlockThoracotomy

Browse More Trials

Cancer trialsLung Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.